EVE to Acquire Nextract, Expanding into $5.3B ED Market
Filed with ASX · · 6 pages · English
EVE Health Group Limited on 6ix
In the deck
Earlier from EVE Health
- Suspension from Quotation
- Quarterly Activities/Appendix 5B Cash Flow Report
- Preliminary Final Report
- Sale of Robyndale Property (Amended)
- Sale of Robyndale Property
Later from EVE Health
- Reinstatement to Quotation
- Notice of General Meeting/Proxy Form
- Results of Meeting
- EVE Completes Nextract Acquisition
- Prescribing Agreement for ED and Dysmenorrhea Products
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health